Published in Mol Carcinog on April 01, 2009
Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N Engl J Med (2014) 7.64
Genome engineering with zinc-finger nucleases. Genetics (2011) 4.66
Chromosomal translocations induced at specified loci in human stem cells. Proc Natl Acad Sci U S A (2009) 2.73
DNA interstrand crosslink repair in mammalian cells: step by step. Crit Rev Biochem Mol Biol (2010) 1.82
Triplex technology in studies of DNA damage, DNA repair, and mutagenesis. Biochimie (2011) 1.67
Selective Preference of Parallel DNA Triplexes Is Due to the Disruption of Hoogsteen Hydrogen Bonds Caused by the Severe Nonisostericity between the G*GC and T*AT Triplets. PLoS One (2016) 1.39
Cellular uptake and intracellular trafficking of antisense and siRNA oligonucleotides. Bioconjug Chem (2011) 1.32
Homology-directed Fanconi anemia pathway cross-link repair is dependent on DNA replication. Nat Struct Mol Biol (2011) 1.29
Potential in vivo roles of nucleic acid triple-helices. RNA Biol (2011) 1.20
Targeting and processing of site-specific DNA interstrand crosslinks. Environ Mol Mutagen (2010) 1.05
Nanoparticle delivery of antisense oligonucleotides and their application in the exon skipping strategy for Duchenne muscular dystrophy. Nucleic Acid Ther (2014) 0.97
Homologous recombination assay for interstrand cross-link repair. Methods Mol Biol (2011) 0.95
Targeting of an interrupted polypurine:polypyrimidine sequence in mammalian cells by a triplex-forming oligonucleotide containing a novel base analogue. Biochemistry (2010) 0.92
2'-Fluoro-modified phosphorothioate oligonucleotide can cause rapid degradation of P54nrb and PSF. Nucleic Acids Res (2015) 0.89
Systemic delivery of triplex-forming PNA and donor DNA by nanoparticles mediates site-specific genome editing of human hematopoietic cells in vivo. Gene Ther (2012) 0.87
Oligo/polynucleotide-based gene modification: strategies and therapeutic potential. Oligonucleotides (2011) 0.87
In vivo correction of anaemia in β-thalassemic mice by γPNA-mediated gene editing with nanoparticle delivery. Nat Commun (2016) 0.86
An update on targeted gene repair in mammalian cells: methods and mechanisms. J Biomed Sci (2011) 0.84
Conjugation with receptor-targeted histidine-rich peptides enhances the pharmacological effectiveness of antisense oligonucleotides. Bioconjug Chem (2013) 0.83
Origins of Programmable Nucleases for Genome Engineering. J Mol Biol (2015) 0.83
Selection of RNA aptamers that bind HIV-1 LTR DNA duplexes: strand invaders. Nucleic Acids Res (2010) 0.80
Targeted gene correction using psoralen, chlorambucil and camptothecin conjugates of triplex forming peptide nucleic acid (PNA). Artif DNA PNA XNA (2011) 0.76
Targeted genome modification via triple helix formation. Methods Mol Biol (2014) 0.75
A study of the ultrasound-targeted microbubble destruction based triplex-forming oligodexinucleotide delivery system to inhibit tissue factor expression. Mol Med Rep (2014) 0.75
Sequence-specific cleavage of double helical DNA by triple helix formation. Science (1987) 9.20
Site-specific oligonucleotide binding represses transcription of the human c-myc gene in vitro. Science (1988) 5.97
Repair of DNA containing interstrand crosslinks in Escherichia coli: sequential excision and recombination. Proc Natl Acad Sci U S A (1973) 3.87
Homologous recombination in DNA repair and DNA damage tolerance. Cell Res (2008) 3.86
Sequence-specific binding and photocrosslinking of alpha and beta oligodeoxynucleotides to the major groove of DNA via triple-helix formation. Proc Natl Acad Sci U S A (1988) 2.82
Mutagenesis in mammalian cells induced by triple helix formation and transcription-coupled repair. Science (1996) 2.63
Nucleotide excision repair. Prog Nucleic Acid Res Mol Biol (2005) 2.31
Site-specific inhibition of EcoRI restriction/modification enzymes by a DNA triple helix. Nucleic Acids Res (1990) 2.12
Specificity in formation of triple-stranded nucleic acid helical complexes: studies with agarose-linked polyribonucleotide affinity columns. Biochemistry (1988) 2.09
Targeted mutagenesis in mammalian cells mediated by intracellular triple helix formation. Mol Cell Biol (1995) 2.05
Specific mutations induced by triplex-forming oligonucleotides in mice. Science (2000) 1.98
Damage recognition in nucleotide excision repair of DNA. Gene (2000) 1.97
Single-site enzymatic cleavage of yeast genomic DNA mediated by triple helix formation. Nature (1991) 1.91
Site-specific cleavage of a yeast chromosome by oligonucleotide-directed triple-helix formation. Science (1990) 1.84
Sequence-specific artificial photo-induced endonucleases based on triple helix-forming oligonucleotides. Nature (1990) 1.84
A triplex-forming sequence from the human c-MYC promoter interferes with DNA transcription. J Biol Chem (2007) 1.62
PNA Technology. Mol Biotechnol (2004) 1.58
Targeted gene knockout mediated by triple helix forming oligonucleotides. Nat Genet (1998) 1.51
Human XPA and RPA DNA repair proteins participate in specific recognition of triplex-induced helical distortions. Proc Natl Acad Sci U S A (2002) 1.49
Mismatch repair participates in error-free processing of DNA interstrand crosslinks in human cells. EMBO Rep (2005) 1.46
Triple-helix formation induces recombination in mammalian cells via a nucleotide excision repair-dependent pathway. Mol Cell Biol (2000) 1.40
Site-directed recombination via bifunctional PNA-DNA conjugates. Proc Natl Acad Sci U S A (2002) 1.32
Recombination induced by triple-helix-targeted DNA damage in mammalian cells. Mol Cell Biol (1996) 1.27
Targeted correction of an episomal gene in mammalian cells by a short DNA fragment tethered to a triplex-forming oligonucleotide. J Biol Chem (1999) 1.27
Human XPC-hHR23B interacts with XPA-RPA in the recognition of triplex-directed psoralen DNA interstrand crosslinks. Nucleic Acids Res (2005) 1.27
Correction of a splice-site mutation in the beta-globin gene stimulated by triplex-forming peptide nucleic acids. Proc Natl Acad Sci U S A (2008) 1.25
Altered repair of targeted psoralen photoadducts in the context of an oligonucleotide-mediated triple helix. J Biol Chem (1995) 1.22
Endonuclease-induced, targeted homologous extrachromosomal recombination in Xenopus oocytes. Proc Natl Acad Sci U S A (1995) 1.22
Triplex-induced recombination in human cell-free extracts. Dependence on XPA and HsRad51. J Biol Chem (2001) 1.21
Triplex targeted genomic crosslinks enter separable deletion and base substitution pathways. Nucleic Acids Res (2005) 1.07
Trapping DNA polymerases using triplex-forming oligodeoxyribonucleotides. Gene (1994) 1.07
Targeting DNA with triplex-forming oligonucleotides to modify gene sequence. Biochimie (2008) 1.04
Reversible inhibition of gene expression by a psoralen functionalized triple helix forming oligonucleotide in intact cells. J Biol Chem (1994) 1.04
Repair and recombination induced by triple helix DNA. Front Biosci (2007) 1.04
Repair of triple helix directed psoralen adducts in human cells. Nucleic Acids Res (1994) 1.03
Defining the function of XPC protein in psoralen and cisplatin-mediated DNA repair and mutagenesis. Carcinogenesis (2003) 1.03
Triple helix-forming oligonucleotides target psoralen adducts to specific chromosomal sequences in human cells. Nucleic Acids Res (1999) 1.00
Efficient inhibition of transcription elongation in vitro by oligonucleotide phosphoramidates targeted to proviral HIV DNA. J Mol Biol (1996) 1.00
Asymmetric recognition of psoralen interstrand crosslinks by the nucleotide excision repair and the error-prone repair pathways. J Mol Biol (1999) 0.95
Detection and determination of oligonucleotide triplex formation-mediated transcription-coupled DNA repair in HeLa nuclear extracts. Nucleic Acids Res (2001) 0.95
Intermolecular triplex formation distorts the DNA duplex in the regulatory region of human papillomavirus type-11. J Biol Chem (1992) 0.93
Distance and affinity dependence of triplex-induced recombination. Biochemistry (2005) 0.93
In vivo persistence of DNA triple helices containing psoralen-conjugated oligodeoxyribonucleotides. Nucleic Acids Res (1996) 0.92
Targeted gene knock in and sequence modulation mediated by a psoralen-linked triplex-forming oligonucleotide. J Biol Chem (2008) 0.92
Covalent crosslinks introduced via a triple helix-forming oligonucleotide coupled to psoralen are inefficiently repaired. Nucleic Acids Res (1999) 0.92
Extensive sugar modification improves triple helix forming oligonucleotide activity in vitro but reduces activity in vivo. Biochemistry (2007) 0.92
Triple helix-directed psoralen crosslinks are recognized by Uvr(A)BC excinuclease. J Mol Biol (1998) 0.91
Retracted Triplex-forming oligonucleotide-orthophenanthroline conjugates for efficient targeted genome modification. Proc Natl Acad Sci U S A (2008) 0.90
Triplex-induced recombination and repair in the pyrimidine motif. Nucleic Acids Res (2005) 0.89
Self-association of G-rich oligodeoxyribonucleotides under conditions promoting purine-motif triplex formation. Antisense Nucleic Acid Drug Dev (1998) 0.89
Repair of sequence-specific 125I-induced double-strand breaks by nonhomologous DNA end joining in mammalian cell-free extracts. J Biol Chem (2002) 0.88
Psoralen adducts induced by triplex-forming oligonucleotides are refractory to repair in HeLa cells. J Mol Biol (2000) 0.87
Psoralen interstrand cross-link repair is specifically altered by an adjacent triple-stranded structure. Nucleic Acids Res (2004) 0.85
Gene targeted DNA double-strand break induction by (125)I-labeled triplex-forming oligonucleotides is highly mutagenic following repair in human cells. Nucleic Acids Res (1999) 0.83
Mutational response of Fanconi anaemia cells to shuttle vector site-specific psoralen cross-links. Carcinogenesis (1995) 0.82
Repair of triplex-directed DNA alkylation by nucleotide excision repair. Nucleic Acids Res (2001) 0.78
Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status. Lancet (2002) 3.04
MicroRNA regulation of DNA repair gene expression in hypoxic stress. Cancer Res (2009) 2.93
Decreased expression of the DNA mismatch repair gene Mlh1 under hypoxic stress in mammalian cells. Mol Cell Biol (2003) 2.12
Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells. Mol Cell Biol (2004) 2.09
Hypoxia-induced down-regulation of BRCA1 expression by E2Fs. Cancer Res (2005) 2.02
Regulation of DNA repair in hypoxic cancer cells. Cancer Metastasis Rev (2007) 1.99
Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance. Cancer Res (2008) 1.70
Hypoxia-induced genetic instability--a calculated mechanism underlying tumor progression. J Mol Med (Berl) (2006) 1.66
Molecular and cellular pharmacology of the hypoxia-activated prodrug TH-302. Mol Cancer Ther (2011) 1.58
Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells. Cancer Biol Ther (2011) 1.50
Human XPA and RPA DNA repair proteins participate in specific recognition of triplex-induced helical distortions. Proc Natl Acad Sci U S A (2002) 1.49
Inhibition of poly(ADP-ribose) polymerase down-regulates BRCA1 and RAD51 in a pathway mediated by E2F4 and p130. Proc Natl Acad Sci U S A (2010) 1.47
Genetic instability and the tumor microenvironment: towards the concept of microenvironment-induced mutagenesis. Mutat Res (2005) 1.37
Site-directed recombination via bifunctional PNA-DNA conjugates. Proc Natl Acad Sci U S A (2002) 1.32
Correction of a splice-site mutation in the beta-globin gene stimulated by triplex-forming peptide nucleic acids. Proc Natl Acad Sci U S A (2008) 1.25
Hypoxia-induced phosphorylation of Chk2 in an ataxia telangiectasia mutated-dependent manner. Cancer Res (2005) 1.24
Hypoxia down-regulates DNA double strand break repair gene expression in prostate cancer cells. Radiother Oncol (2005) 1.22
Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6. Carcinogenesis (2006) 1.19
The potential for gene repair via triple helix formation. J Clin Invest (2003) 1.19
Hypoxic tumor microenvironment and cancer cell differentiation. Curr Mol Med (2009) 1.19
Site-specific gene modification by PNAs conjugated to psoralen. Biochemistry (2006) 1.16
Emerging roles of microRNAs in the molecular responses to hypoxia. Curr Pharm Des (2009) 1.14
Co-repression of mismatch repair gene expression by hypoxia in cancer cells: role of the Myc/Max network. Cancer Lett (2007) 1.14
Hypoxia-induced epigenetic regulation and silencing of the BRCA1 promoter. Mol Cell Biol (2011) 1.13
Nanoparticles deliver triplex-forming PNAs for site-specific genomic recombination in CD34+ human hematopoietic progenitors. Mol Ther (2010) 1.13
Basal repression of BRCA1 by multiple E2Fs and pocket proteins at adjacent E2F sites. Cancer Biol Ther (2006) 1.09
Targeting cancer with a lupus autoantibody. Sci Transl Med (2012) 1.09
Triplex-forming oligonucleotides: principles and applications. Q Rev Biophys (2002) 1.09
Triplex-forming oligonucleotides as potential tools for modulation of gene expression. Curr Med Chem Anticancer Agents (2005) 1.08
Targeted disruption of the CCR5 gene in human hematopoietic stem cells stimulated by peptide nucleic acids. Chem Biol (2011) 1.05
Repair and recombination induced by triple helix DNA. Front Biosci (2007) 1.04
Emergence of rationally designed therapeutic strategies for breast cancer targeting DNA repair mechanisms. Breast Cancer Res (2010) 1.03
Cell-interdependent cisplatin killing by Ku/DNA-dependent protein kinase signaling transduced through gap junctions. Proc Natl Acad Sci U S A (2004) 1.03
Potentiation of temozolomide cytotoxicity by inhibition of DNA polymerase beta is accentuated by BRCA2 mutation. Cancer Res (2009) 1.02
Repair of DNA interstrand cross-links: interactions between homology-dependent and homology-independent pathways. DNA Repair (Amst) (2006) 1.02
Targeted gene modification of hematopoietic progenitor cells in mice following systemic administration of a PNA-peptide conjugate. Mol Ther (2011) 1.01
Peptide conjugates for chromosomal gene targeting by triplex-forming oligonucleotides. Nucleic Acids Res (2004) 0.98
Functional and physical interaction between the mismatch repair and FA-BRCA pathways. Hum Mol Genet (2011) 0.97
Interplay between DNA repair and inflammation, and the link to cancer. Crit Rev Biochem Mol Biol (2014) 0.96
Alterations in DNA repair gene expression under hypoxia: elucidating the mechanisms of hypoxia-induced genetic instability. Ann N Y Acad Sci (2005) 0.96
Triplex-stimulated intermolecular recombination at a single-copy genomic target. Mol Ther (2006) 0.95
Targeted genome modification via triple helix formation. Ann N Y Acad Sci (2005) 0.95
Gene therapy for autosomal dominant disorders of keratin. J Investig Dermatol Symp Proc (2005) 0.94
Targeted correction of a thalassemia-associated beta-globin mutation induced by pseudo-complementary peptide nucleic acids. Nucleic Acids Res (2009) 0.93
Src-Induced cisplatin resistance mediated by cell-to-cell communication. Cancer Res (2009) 0.93
Distance and affinity dependence of triplex-induced recombination. Biochemistry (2005) 0.93
CHK2-dependent phosphorylation of BRCA1 in hypoxia. Radiat Res (2006) 0.91
The tumor microenvironment and DNA repair. Semin Radiat Oncol (2010) 0.91
microRNAs in cancer cell response to ionizing radiation. Antioxid Redox Signal (2014) 0.90
Preclinical evaluation of Laromustine for use in combination with radiation therapy in the treatment of solid tumors. Int J Radiat Biol (2011) 0.89
Triplex-induced recombination and repair in the pyrimidine motif. Nucleic Acids Res (2005) 0.89
Transcription dependence of chromosomal gene targeting by triplex-forming oligonucleotides. J Biol Chem (2002) 0.89
Overexpression of the DNA mismatch repair factor, PMS2, confers hypermutability and DNA damage tolerance. Cancer Lett (2006) 0.88
Reduced level of ribonucleotide reductase R2 subunits increases dependence on homologous recombination repair of cisplatin-induced DNA damage. Mol Pharmacol (2011) 0.87
Hypoxia-induced protein CAIX is associated with somatic loss of BRCA1 protein and pathway activity in triple negative breast cancer. Breast Cancer Res Treat (2012) 0.86
Site-directed gene mutation at mixed sequence targets by psoralen-conjugated pseudo-complementary peptide nucleic acids. Nucleic Acids Res (2007) 0.86
Triplex-mediated gene modification. Methods Mol Biol (2008) 0.86
Targeted gene modification using triplex-forming oligonucleotides. Methods Mol Biol (2004) 0.85
Targeted cross-linking of the human beta-globin gene in living cells mediated by a triple helix forming oligonucleotide. Biochemistry (2006) 0.84
IGF1 receptor expression protects against microenvironmental stress found in the solid tumor. Radiat Res (2002) 0.84
Site-specific Genome Editing in PBMCs With PLGA Nanoparticle-delivered PNAs Confers HIV-1 Resistance in Humanized Mice. Mol Ther Nucleic Acids (2013) 0.83
Molecular markers in clinical radiation oncology. Oncogene (2003) 0.82
Polymer delivery systems for site-specific genome editing. J Control Release (2011) 0.82
MEN1 and FANCD2 mediate distinct mechanisms of DNA crosslink repair. DNA Repair (Amst) (2008) 0.82
Mlh1-dependent suppression of specific mutations induced in vivo by the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP). Mutat Res (2005) 0.81
Nanoparticle for delivery of antisense γPNA oligomers targeting CCR5. Artif DNA PNA XNA (2013) 0.80
Modified poly(lactic-co-glycolic acid) nanoparticles for enhanced cellular uptake and gene editing in the lung. Adv Healthc Mater (2014) 0.79
Induction of aberrant crypt foci in DNA mismatch repair-deficient mice by the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP). Cancer Lett (2006) 0.77
"Micro"-management of DNA repair genes by hypoxia. Cell Cycle (2009) 0.77
Triplex-forming peptide nucleic acids induce heritable elevations in gamma-globin expression in hematopoietic progenitor cells. Mol Ther (2013) 0.76
Introduction: the evolving picture of the hypoxic tumour microenvironment. Curr Mol Med (2009) 0.76
Radiation sensitivity and sensitization in melanoma. Pigment Cell Melanoma Res (2013) 0.76
Targeted genome modification via triple helix formation. Methods Mol Biol (2014) 0.75
Therapeutic genome mutagenesis using synthetic donor DNA and triplex-forming molecules. Methods Mol Biol (2015) 0.75
Tumor suppressor p53 stole the AKT in hypoxia. J Clin Invest (2015) 0.75
Introduction. Yale J Biol Med (2013) 0.75
Setting standards in gene repair. Oligonucleotides (2004) 0.75
Peptide nucleic acid-mediated recombination for targeted genomic repair and modification. Methods Mol Biol (2014) 0.75
Triplex-mediated genome targeting and editing. Methods Mol Biol (2014) 0.75